Found: 15
Select item for more details and to access through your institution.
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia.
- Published in:
- Nature Genetics, 2014, v. 46, n. 3, p. 245, doi. 10.1038/ng.2889
- By:
- Publication type:
- Article
Combined Population Dynamics and Entropy Modelling Supports Patient Stratification in Chronic Myeloid Leukemia.
- Published in:
- Scientific Reports, 2016, p. 24057, doi. 10.1038/srep24057
- By:
- Publication type:
- Article
MicroRNA-150 Expression Induces Myeloid Differentiation of Human Acute Leukemia Cells and Normal Hematopoietic Progenitors.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0075815
- By:
- Publication type:
- Article
The Prognostic Significance of <i>IRF8</i> Transcripts in Adult Patients with Acute Myeloid Leukemia.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0070812
- By:
- Publication type:
- Article
Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2934, doi. 10.3390/cancers14122934
- By:
- Publication type:
- Article
Small, abnormal B lymphoid blast populations in chronic myelogenous leukemia at diagnosis: Does this finding indicate an accelerated course?
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 5, p. 440, doi. 10.1002/cyto.b.21357
- By:
- Publication type:
- Article
Hyper‐CVAD versus dose‐adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 6, p. 863, doi. 10.1111/ejh.14089
- By:
- Publication type:
- Article
Regulation of myeloid leukaemia by the cell-fate determinant Musashi.
- Published in:
- Nature, 2010, v. 466, n. 7307, p. 765, doi. 10.1038/nature09171
- By:
- Publication type:
- Article
Estimated Savings After Stopping Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myeloid Leukemia.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 12, p. e2347950, doi. 10.1001/jamanetworkopen.2023.47950
- By:
- Publication type:
- Article
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1301, doi. 10.1002/ajh.25238
- By:
- Publication type:
- Article
A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-017-02465-5
- By:
- Publication type:
- Article
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 7, p. 1411, doi. 10.1002/cncr.34073
- By:
- Publication type:
- Article
Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- journal article